##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



---

FORM 10-QSB



---

(Mark One)

|x | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------

FOR THE QUARTERLY PERIOD ENDED JULY 1, 2006



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

FOR THE TRANSITION PERIOD FROM             TO

COMMISSION FILE NUMBER: 000-13858



---

MEDICAL SOLUTIONS MANAGEMENT
INC.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)



---



|                         |  |                                     
|------------------------ |  | ------------------------------------
|Nevada                   |  | 86-0214815                          
|(State of Incorporation) |  | (I.R.S. Employer Identification No.)

237 Cedar Hill Street, Marlborough, MA 01752

(Address of principal executive offices)(Zip Code)

(508) 597-6300

(Registrants telephone number, including area code)

China Media Networks International, Inc.

(Former name, former address and former fiscal year, if changed since last report)



---

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).    Yes ̈No  x

Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date. As of August 15,
2006, there were 20,446,729 shares of the registrants common stock issued and outstanding.

Transitional Small Business Disclosure
Format (Check one):    Yes ̈No  x



---



---

##### Table of Contents

TABLE OF CONTENTS



|        |  |                                                                                                                                        |  |     
|------- |  | -------------------------------------------------------------------------------------------------------------------------------------- |  | ----
|Section |  | Heading                                                                                                                                |  | Page
|Part I  |  | Financial Information                                                                                                                  |  | 4   
|        |  |                                                                                                                                       
|Item 1  |  | Financial Statements                                                                                                                   |  |     
|        |  | Consolidated Balance Sheets (Unaudited) at July 1, 2006                                                                                |  | 4   
|        |  | Consolidated Statement of Operations (Unaudited) from January 1, 2006 to July 1, 2006, and the comparative period for Fiscal Year 2005 |  | 5   
|        |  | Consolidated Statement of Cash Flows (Unaudited) from January 1, 2006 to July 1, 2006, and the comparative period for Fiscal Year 2005 |  | 6   
|        |  | Notes to Financial Statements                                                                                                          |  | 7   
|Item 2  |  | Managements Discussion and Analysis or Plan of Operation                                                                              |  | 13  
|Item 3  |  | Controls and Procedures                                                                                                                |  | 19  
|        |  |                                                                                                                                       
|Part II |  | Other Information                                                                                                                      |  |     
|        |  |                                                                                                                                       
|Item 1  |  | Legal Proceedings                                                                                                                      |  | 21  
|Item 2  |  | Unregistered Sales of Equity Securities and Use of Proceeds                                                                            |  | 21  
|Item 3  |  | Defaults Upon Senior Notes                                                                                                             |  | 21  
|Item 4  |  | Submission of Matters to a Vote to Security Holders                                                                                    |  | 21  
|Item 5  |  | Other Information                                                                                                                      |  | 22  
|Item 6  |  | Exhibits                                                                                                                               |  | 22  
|        |  |                                                                                                                                       
|        |  | Signatures                                                                                                                             |  | 24  



- 2 -



---

##### Table of Contents

Explanatory Notes

Unless the context otherwise requires, in this quarterly report on Form 10-QSB the term MSMI refers Medical Solutions Management Inc. and the term OrthoSupply refers to MSMIs wholly-owned
subsidiary, OrthoSupply Management, Inc. The terms the Company, we, us or our refer to MSMI and OrthoSupply collectively. The term Securities Act refers to the Securities Act of 1933, as
amended, the term Exchange Act refers to the Securities Exchange Act of 1934, as amended, and the term SEC refers to the Securities and Exchange Commission.

Note on Forward-Looking Information

Except for historical facts, the statements in
this quarterly report on Form 10-QSB are forward-looking statements. Forward-looking statements are merely our current predictions of future events. These statements are inherently uncertain, and actual events could differ materially from our
predictions. Important factors that could cause actual events to vary from our predictions include those discussed under the headings Risk Factors, Managements Discussion and Analysis or Plan of Operations and
Business in our Annual Report on Form 10-KSB for fiscal year ended December 31, 2005. We assume no obligation to update our forward-looking statements to reflect new information or developments. We urge readers to review
carefully the risk factors described in the Annual Report on Form 10-KSB for fiscal year ended December 31, 2005 and the other documents that we file with the SEC. You can read these documents at www.sec.gov



- 3 -



---

##### Table of Contents

PART I FINANCIAL INFORMATION

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Balance Sheet (unaudited)

July 1, 2006



|                                                                                      |  |                    |            |  
|------------------------------------------------------------------------------------- |  | ------------------ | ---------- | -
|                                                                                      |  | As of July 1, 2006 |           
|Assets                                                                                |  |                    |            |  
|Current Assets                                                                        |  |                    |            |  
|Cash & cash equivalents                                                               |  | $                  | 1,426,221  |  
|Accounts receivable, net                                                              |  |                    | 189,285    |  
|Inventory                                                                             |  |                    | 103,048    |  
|Prepaid expenses                                                                      |  |                    | 39,886     |  
|                                                                                      |  |                    |            |  
|Total current assets                                                                  |  |                    | 1,758,440  |  
|                                                                                      | 
|Property & equipment (net)                                                            |  |                    | 91,386     |  
|                                                                                      |  |                    |            |  
|Total assets                                                                          |  | $                  | 1,849,826  |  
|                                                                                      | 
|Liabilities & Stockholders Equity                                                    |  |                    |            |  
|Current Liabilities:                                                                  |  |                    |            |  
|Accounts payable                                                                      |  | $                  | 114,372    |  
|Accrued expenses                                                                      |  |                    | 172,284    |  
|Demand notes                                                                          |  |                    | 0          |  
|Advances from related parties                                                         |  |                    | 0          |  
|Convertible notes payable                                                             |  |                    | 25,000     |  
|                                                                                      |  |                    |            |  
|Total current liabilities                                                             |  |                    | 311,656    |  
|Convertible notes payable long term (net)                                            |  |                    | 1,179,856  |  
|Total long-term liabilities                                                           |  |                    | 1,179,856  |  
|                                                                                      |  |                    |            |  
|Total Liabilities                                                                     |  |                    | 1,491,512  |  
|                                                                                      | 
|Stockholders Equity:                                                                 |  |                    |            |  
|Preferred stock-5,000,000 authorized $0.001 par value                                 |  |                    |            |  
|                                                                                      |  |                    | 0          |  
|Common stock-100,000,000 authorized $0.0001 par value 20,446,729 issued & outstanding |  |                    | 2,044      |  
|Treasury Stock                                                                        |  |                    | (898,327   | )
|Additional paid in capital                                                            |  |                    | 4,107,343  |  
|Accumulated Deficit                                                                   |  |                    | (2,852,746 | )
|                                                                                      |  |                    |            |  
|Total Stockholders Equity                                                            |  |                    | 358,314    |  
|                                                                                      |  |                    |            |  
|Total Liabilities & Equity                                                            |  | $                  | 1,849,826  |  

See Notes to Interim Financial Statements.



- 4 -



---

##### Table of Contents

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Statement of Operations from January 1, 2006 to July 1, 2006 (unaudited)

and the comparative period for Fiscal Year 2005



|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|-------------------------------------------------- |  | ----------------------------- | ---------- | - | ----------------------------- | - | ---------- | ------------------------------- |  | - | ------------------------------- | - |  | - | ---------- | -
|                                                   |  | Six Months Ended July 1, 2006 |            |   | Six Months Ended July 2, 2005 |   |            | Three Months Ended July 1, 2006 |  |   | Three Months Ended July 2, 2005 |  
|Revenue:                                           |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Sales                                              |  | $                             | 407,165    |   |                               | $ | 147,899    |                                 |  | $ | 253,502                         |   |  | $ | 127,045    |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Total revenue                                      |  |                               | 407,165    |   |                               |   | 147,899    |                                 |  | $ | 253,502                         |   |  | $ | 127,045    |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Cost of Sales:                                     |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Cost of goods & services                           |  |                               | 339,185    |   |                               |   | 102,287    |                                 |  |   | 229,262                         |   |  |   | 69,867     |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Costs Applicable to Sales & Revenue                |  |                               | 339,185    |   |                               |   | 102,287    |                                 |  |   | 229,262                         |   |  |   | 69,867     |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Gross Profit                                       |  |                               | 67,980     |   |                               |   | 45,612     |                                 |  |   | 24,240                          |   |  |   | 57,178     |  
|                                                   |  |                               | 16.7       | % |                               |   | 30.8       | %                               |  |   | 9.5                             | % |  |   | 45.0       | %
|                                                   |  |                               |            |  
|Selling, General & Administrative Expenses         |  |                               | 1,324,954  |   |                               |   | 203,862    |                                 |  |   | 830,979                         |   |  |   | 162,431    |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Total Operating Expenses                           |  |                               | 1,324,954  |   |                               |   | 203,862    |                                 |  |   | 830,979                         |   |  |   | 162,431    |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|(Loss) Before Other Income                         |  |                               | (1,256,974 | ) |                               |   | (158,250   | )                               |  |   | (806,739                        | ) |  |   | (105,253   | )
|Other Income (Expense)                             |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Interest Income                                    |  |                               | 3,514      |   |                               |   | 0          |                                 |  |   | 1,505                           |   |  |   | 0          |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Other Income                                       |  |                               | 0          |   |                               |   | 0          |                                 |  |   | 0                               |   |  |   | 0          |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Interest (expense), net                            |  |                               | (820,144   | ) |                               |   | 0          |                                 |  |   | (820,144                        | ) |  |   | 0          |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|(Loss) Before Income Taxes                         |  |                               | (2,073,604 | ) |                               |   | (158,250   | )                               |  |   | (1,625,378                      | ) |  |   | (105,253   | )
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Income Taxes                                       |  |                               | 669        |   |                               |   | 0          |                                 |  |   | 0                               |   |  |   | 0          |  
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Net Loss available to common shareholders          |  | $                             | (2,074,273 | ) |                               | $ | (158,250   | )                               |  | $ | (1,625,378                      | ) |  | $ | (105,253   | )
|                                                   |  |                               |            |   |                               |   |            |                                 |  |   |                                 |   |  |   |            |  
|Basic and Diluted Net Loss Per Common Share        |  | $                             | (0.10      | ) |                               | $ | (0.009     | )                               |  | $ | (0.07                           | ) |  | $ | (0.006     | )
|                                                   |  |                               |            |  
|Weighted Average Common Shares Outstanding (Basic) |  |                               | 20,771,459 |   |                               |   | 17,736,619 |                                 |  |   | 21,776,716                      |   |  |   | 17,736,619 |  

See Notes to Interim Financial Statements.



- 5 -



---

##### Table of Contents

Medical Solutions Management Inc.

(Formerly China Media Networks International, Inc.)

Consolidated Statement of Cash Flows from January 1, 2006 to July 1, 2006 (unaudited)

and the comparative period for Fiscal Year 2005



|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|--------------------------------------------------------------------------------------------------------------------------------- |  | ----------------------------- | ---------- | - | ----------------------------- | - | -------- | -
|                                                                                                                                  |  | Six Months Ended July 1, 2006 |            |   | Six Months Ended July 2, 2005 |  
|Cash Flows from Operating Activities:                                                                                             |  |                               |            |   |                               |   |          |  
|Net Income                                                                                                                        |  | $                             | (2,074,273 | ) |                               | $ | (158,250 | )
|Adjustments required to reconcile net loss to cash flows from operating activities:                                               |  |                               |            |   |                               |   |          |  
|Increase in allowance for doubtful accounts                                                                                       |  |                               | 21,616     |   |                               |   |          |  
|Depreciation, Amortization & Bad Debts                                                                                            |  |                               | 17,683     |   |                               |   | 1,820    |  
|Non-cash interest expense                                                                                                         |  |                               | 820,144    |   |                               |   |          |  
|Stock issued for services                                                                                                         |  |                               | 102,581    |   |                               |   |          |  
|Changes in Operating Assets & Liabilities                                                                                         |  |                               |            |   |                               |   |          |  
|Accounts receivable                                                                                                               |  |                               | (84,545    | ) |                               |   | (95,097  | )
|Inventory                                                                                                                         |  |                               | 5,989      |   |                               |   | (64,569  | )
|Prepaid expenses                                                                                                                  |  |                               | (12,367    | ) |                               |   |          |  
|Accounts payable                                                                                                                  |  |                               | (203,619   | ) |                               |   | 59,675   |  
|Accrued expenses                                                                                                                  |  |                               | 139,684    |   |                               |   | 19,605   |  
|Loan payable                                                                                                                      |  |                               |            |   |                               |   | 39,257   |  
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Net cash used by operating activities                                                                                             |  |                               | (1,267,107 | ) |                               |   | (197,559 | )
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Cash Flows from Investing Activities:                                                                                             |  |                               |            |   |                               |   |          |  
|Purchase of Equipment                                                                                                             |  |                               | (6,412     | ) |                               |   | (15,090  | )
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Net cash used by investing activities                                                                                             |  |                               | (6,412     | ) |                               |   | (15,090  | )
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Cash Flows from Financing Activities:                                                                                             |  |                               |            |   |                               |   |          |  
|Convertible notes payable                                                                                                         |  |                               | 2,000,000  |   |                               |   | 0        |  
|Proceeds from preferred offering                                                                                                  |  |                               | 0          |   |                               |   | 0        |  
|Purchase of treasury stock                                                                                                        |  |                               | (0         |   |                               |   | 0        |  
|Payment of offering costs                                                                                                         |  |                               | 0          |   |                               |   | 0        |  
|Borrowings from related parties                                                                                                   |  |                               | 0          |   |                               |   | 215,924  |  
|Payment of related party debt                                                                                                     |  |                               | 0          |   |                               |   | 0        |  
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Net cash used by financing activities                                                                                             |  |                               | 2,000,000  |   |                               |   | 215,924  |  
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Net Change In Cash                                                                                                                |  |                               | 726,481    |   |                               |   | 3,275    |  
|Cash-Beginning                                                                                                                    |  |                               | 699,740    |   |                               |   | 0        |  
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|Cash-Ending                                                                                                                       |  | $                             | 1,426,221  |   |                               | $ | 3,275    |  
|                                                                                                                                  |  |                               |            |   |                               |   |          |  
|                                                                                                                                  |  |                              
|Supplemental disclosure of non-cash transactions:                                                                                 |  |                               |            |   |                               |   |          |  
|Value of common stock warrants issued for services                                                                                |  |                               | 87,581     |   |                               |   | 0        |  
|Value of common stock warrants issued for interest expenses                                                                       |  |                               | 820,144    |   |                               |   | 0        |  
|Value of discount to convertible debenture arising from computed beneficial conversion feature                                    |  |                               | 820,144    |   |                               |   | 0        |  
|Return of 1,694,419 of common stock to treasury based on the reduction of the conversion price on the Vicis convertible
debenture |  |                               | 898,327    |   |                               |   | 0        |  

See Notes to Interim Financial Statements.



- 6 -



---

##### Table of Contents

MEDICAL SOLUTIONS MANAGEMENT INC.

NOTES TO UNAUDITED FINANCIALS STATEMENTS

1. Basis of Presentation

The Financial Statements presented herein
have been prepared by us in accordance with the accounting policies described in our Annual Report on Form 10-KSB for fiscal year ended December 31, 2005 and should be read in conjunction with the Notes to Consolidated Financial Statements
which appear in that report.

The preparation of these financial statements in conformity with accounting principles generally accepted in the United
States requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on going basis, we evaluate our estimates,
including those related intangible assets, income taxes, insurance obligations and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other resources. Actual results may differ from these estimates under different
assumptions or conditions.

In the opinion of management, the information furnished in this Form 10-QSB reflects all adjustments necessary for a fair
statement of the financial position and results of operations and cash flows as of and for the three-month and six-month periods ended July 1, 2006 and July 2, 2005. All such adjustments are of a normal recurring nature. The Consolidated
Financial Statements have been prepared in accordance with the instructions to Form 10-QSB and therefore do not include some information and notes necessary to conform with annual reporting requirements.

2. Earnings/Loss Per Share

Basic earnings per share are computed by
dividing income available to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. Diluted earnings per share assume that any dilutive convertible securities outstanding
were converted, with related preferred stock dividend requirements and outstanding common shares adjusted accordingly. It also assumes that outstanding common shares were increased by shares issuable upon exercise of those stock options for which
market price exceeds the exercise price, less shares which could have been purchased by us with the related proceeds. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other
potential shares outstanding would be anti-dilutive.

3. New Accounting Standards

In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, which replaces APB Opinion No. 20 Accounting Changes, and FASB Statement No. 3
Reporting Accounting Changes in Interim Financial Statements, and changes the requirements for the accounting for and reporting of a change in accounting principle. This Statement requires retrospective application to prior periods
financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. This Statement is effective for accounting changes and corrections of errors
made in fiscal years beginning after December 15, 2005. Early adoption is permitted for accounting changes and corrections of errors made in fiscal years beginning after the date this Statement is issued. We do not believe that adoption of SFAS
154 will have a material impact on our financial statements.



- 7 -



---

##### Table of Contents

4. Convertible Note Payable

On June 28, 2006, we issued a $2.0 million convertible promissory note to Vicis Capital Master Fund. The note bears interest at 6% per annum until paid or converted. Interest shall accrue on the basis of a 360-day year of
twelve 30-day months and payable to Vicis on the maturity date. The convertible note matures on June 28, 2008. The conversion rate is approximately $0.21 per share (subject to certain anti-dilution provisions).

In accordance with the FASB Emerging Issues Task Force (EITF) Issue No. 98-5 Accounting for Convertible Securities with Beneficial Conversion
Features or Contingently Adjustable Conversion Ratios and EITF Issue No. 00-27 Application of Issue No. 98-5 to Certain Convertible Instruments, we determined that the convertible note contains an imbedded beneficial
conversion feature resulting in a discount to the carrying amount of the notes equal to:



|(i) | the difference between the stated conversion rate and the market price of our common stock on the date of issuance; multiplied by
|--- | ---------------------------------------------------------------------------------------------------------------------------------



|(ii) | the number of shares into which the notes are convertible. Per EITF Issue No. 98-5 and EITF Issue No. 00-27, upon issuance we recorded an $820,144 discount to the
convertible notes.
|---- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

For convertible debt securities, any recorded discount resulting from the allocation of proceeds to the beneficial
conversion feature should be recognized as interest expense over the minimum period from the date of issuance to the date at which the debt holder can realize that return (that is, through the date of earliest conversion ) using the effective yield
method. Since the debt holder can realize the benefit of conversion immediately, we have recorded the entire discount as interest expense in the period in which the note was issued.

Discount arising from the allocation of a portion of the proceeds to the equity component based upon relative fair value resulted in a discount of $820,144. This discount will be amortized to interest expense over the
term of the note using the effective yield method. A schedule of accretion of the carrying value of the note and corresponding amortization of discount is as follows:



|                                      |  |   |           |   |  |   |       
|------------------------------------- |  | - | --------- | - |  | - | ------
|Face amount of note(s)                |  | $ | 2,000,000 |   |  | $ | 25,000
|Amortization of discount through 2006 |  |   | (166,645  | ) |  |   | 0     
|Amortization of discount through 2007 |  |   | (405,975  | ) |  |   | 0     
|Amortization of discount through 2008 |  |   | (247,524  | ) |  |   | 0     
|                                      |  |   |           |   |  |   |       
|Current carrying value                |  | $ | 1,179,856 |   |  | $ | 25,000

The impact of other related, recently issued, pronouncements are summarized as
follows:

EITF Issue 04-8, The Effect of Contingently Convertible Instruments on Diluted Earnings per Share. The EITF reached a consensus
that contingently convertible instruments, such as contingently convertible debt, contingently convertible preferred stock, and other such securities should be included in diluted



- 8 -



---

##### Table of Contents

earnings per share (if dilutive) regardless of whether the market price trigger has been met. The consensus became
effective for reporting periods ending after December 15, 2004. The adoption of this pronouncement does not currently have an effect on the Companys financial statements because the inclusion of common stock equivalents in earnings per
share is anti-dilutive.

In September 2005, the FASB ratified the Emerging Issues Task Forces (EITF) Issue No. 05-7,
Accounting for Modifications to Conversion Options Embedded in Debt Instruments and Related Issues, which addresses whether a modification to a conversion option that changes its fair value affects the recognition of interest expense for
the associated debt instrument after the modification and whether a borrower should recognize a beneficial conversion feature not a debt extinguishment if a debt modification increases the intrinsic value of the debt (for example, the modification
reduces the conversion price of the debt). In September 2005, the FASB also ratified the EITFs Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneficial Conversion Feature, which discusses
whether the issuance of convertible debt with a beneficial conversion feature results in a basis difference arising from the intrinsic value of the beneficial conversion feature on the commitment date (which is treated recorded in the
shareholders equity for book purposes, but as a liability for income tax purposes), and, if so, whether that basis difference is a temporary difference under FASB Statement No. 109, Accounting for Income Taxes. The
Company is currently in the process of evaluating the effect that the adoption of this pronouncement may have on its financial statements.

In
September 2005, the FASB also ratified the EITFs Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneficial Conversion Feature, which discusses whether the issuance of convertible debt with a
beneficial conversion feature results in a basis difference arising from the intrinsic value of the beneficial conversion feature on the commitment date (which is treated recorded in the shareholders equity for book purposes, but as a
liability for income tax purposes), and, if so, whether that basis difference is a temporary difference under FASB Statement No. 109, Accounting for Income Taxes. We currently carry an allowance for all deferred taxes and,
therefore we do not believe the adoption of this pronouncement will have any impact on our financial statements.

5. Stockholders Equity

Recent Sales of Unregistered Securities

Pursuant
to the Exchange Agreement among the Registrant, Vicis, Midtown Partners & Co., LLC and Nite Capital L.P., dated as of April 13, 2006, such shareholders assigned, exchanged and converted their right, title and interest to shares of the
Registrants then outstanding Series A Preferred Stock and, in exchange thereof and upon such conversion, the Registrant issued such shareholders shares of the Registrants common stock, as set forth below, and, as a result, there are no
shares of Series A Preferred Stock presently outstanding.



|                            |  |                                                                                |  |                                        
|--------------------------- |  | ------------------------------------------------------------------------------ |  | ---------------------------------------
|Shareholder                 |  | Number of Shares of Series A Preferred Stock Assigned, Exchanged
and Converted |  | Number of Shares of Common Stock Issued
|Vicis Capital Master Fund   |  | 1,500,000                                                                      |  | 2,000,000                              
|Midtown Partners & Co., LLC |  | 90,000                                                                         |  | 120,000                                
|Nite Capital L.P.           |  | 110,000                                                                        |  | 220,000                                

On May 3, 2006, the Registrant entered into a Securities Purchase Agreement with Vicis, pursuant to



9



---

##### Table of Contents

which the Registrant sold a convertible note in the original principal amount of $300,000 and 300,000 shares of the
Registrants common stock, in exchange for $300,000. Vicis surrendered the note as partial consideration for the 6% senior secured convertible debenture described above.

On June 28, 2006, the Registrant consummated a Securities Purchase and Exchange Agreement with Vicis Capital Master Fund, or Vicis. Pursuant to this agreement, the Registrant sold to Vicis a 6% senior secured
convertible debenture in the original principal amount of $2,000,000, a warrant to purchase 8,000,000 shares of the Registrants common stock, exercisable for five years at a price of $0.345 per share, and a warrant to purchase 8,000,000 shares
of the Registrants common stock, exercisable for five years at price of $0.375 per share. As consideration there of, Vicis paid the Registrant $1,700,000 cash less $60,000 for incurred expenses and surrendered a convertible note in the
principal amount of $300,000 previously sold to Vicis on May 3, 2006 and 1,994,419 shares of the Registrants common stock.

On June 28,
2006, the Registrant issued to FP Associates a warrant to purchase 300,000 shares of the Registrants common stock, exercisable for five years at a price of $0.01 per share, in consideration for services rendered to the Registrant. The
Registrant relied upon Rule 506 of Regulation D of the Securities Act of 1933, as amended, for the issuance of the debenture and warrants to Vicis and the warrant to FP Associates.

6. Stock-Based Compensation-Adoption of SFAS 123R

On January 1, 2006, the Company adopted the provisions of
Statement of Financial Accounting Standards (SFAS) 123R, Share-Based Payment (SFAS 123(R)), which requires that companies measure and recognize compensation expense at an amount equal to the fair value of
share-based payments granted under compensation arrangements. Prior to January 1, 2006, the Company accounted for its stock-based compensation plans under the recognition and measurement principles of Accounting Principles Board
(APB) Opinion 25, Accounting for Stock Issued to Employees, and related interpretations, and recognized no compensation expense for stock option grants since all options granted had an exercise price equal to the market value
of the underlying common stock on the date of grant.

The Company adopted SFAS 123(R) using the modified prospective method, which results in
no restatement of prior period amounts. Under this method, the provisions of SFAS 123(R) apply to all awards granted or modified after the date of adoption. In addition, compensation expense must be recognized for any unvested stock option awards
outstanding as of the date of adoption on a straight-line basis over the remaining vesting period. The Company calculates the fair value of options using a Black-Scholes option pricing model.

Solely for purposes of the following discussion in this Note 6, the June 28, 2006 issuance by the Company to FP Associates of a warrant to purchase 300,000 shares
of the Companys common stock is deemed to be a grant of a stock option since the issuance was made in consideration of services rendered to the Company. Accordingly, for the six months ended July 1, 2006, the Companys compensation
expense related to stock option grants was $87,581, which represents the expense associated with the issuance of the warrant to FP Associates. A summary of assumptions is as follows:



|     |  |               |   |  |                |   |  |                     |   |  |              
|---- |  | ------------- | - |  | -------------- | - |  | ------------------- | - |  | -------------
|Year |  | Interest Rate |   |  | Dividend Yield |   |  | Expected Volatility |   |  | Expected Life
|2006 |  | 5.0           | % |  | 0.0            | % |  | 30.0                | % |  | 60 mos.      
|2005 |  | 4.0           | % |  | 0.0            | % |  | 50.0                | % |  | 60 mos.      



- 10 -



---

##### Table of Contents

SFAS 123(R) also requires the benefits of tax deductions in excess of recognized compensation expense to be reported in
the Statement of Cash Flows as a financing cash inflow rather than an operating cash inflow. In addition, SFAS 123(R) required a modification to the Companys calculation of the dilutive effect of stock option awards on earnings per share. For
companies that adopt SFAS 123(R) using the modified prospective method, disclosure of pro forma information for periods prior to adoption must continue to be made.

As of July 1, 2006, there was no unrecognized compensation cost related to non-vested options granted under the plan. The total fair value of shares issued and vested during the six-month period ended
July 1, 2006 was $87,581, which represents the expense associated with the issuance of the warrant to FP Associates (none during the six-month period ended July 1, 2005).

The following table summarizes the status of the Companys aggregate options as of July 1, 2006, including the issuance by the Company of the warrant to FP Associates:



|                         |  |                     |   |                                           |                                 |                     |  |        |  |                                 |  |   |     
|------------------------ |  | ------------------- | - | ----------------------------------------- | ------------------------------- | ------------------- |  | ------ |  | ------------------------------- |  | - | ----
|                         |  | Options Outstanding |   | Weighted average remaining life in months |                                 | Options Exercisable
|Range of exercise prices |  | Shares              |   |                                           | weighted average exercise price |                     |  | Shares |  | weighted average exercise price
|$ .01-$ .74              |  | 900,000             | * |                                           | $                               | 0.01                |  | 39.6   |  | 900,000                         |  | $ | 0.01

---

|* | Includes options to purchase an aggregate 600,000 shares of common stock of OrthoSupply to be converted to substantially equivalent options in MSMI under its 2006 Equity Incentive
Plan.
|- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

7. Managements Plan

Our
main objectives for the next 12 months are continuing our ability to finance the Company and focusing on expanding revenue in key locations across the country. We expect that our current cash availability will support current operations through the
end of 2006. We anticipate that we will need to complete additional financing to support current working capital needs and potential acquisitions. Through these financings, we hope to expand the business organically and acquisitively.

Our plan for organic growth includes increasing our sales force in key locations across the country. In fiscal year 2006, we plan to build our sales force from our
current level, 4 sales people, to 10 sales people. The plan includes support programs for the sales efforts including marketing, communications and program literature.

We also plan to increase our resources in administration, and to add one to three additional employees to assist with our service administration. During the first six months of 2006, we hired two additional customer
support specialists and two field representative in order to carry out our current service model. We expect to hire additional field support resources to support the growth in new clinics during 2006.

We do not anticipate devoting our resources to research and development in fiscal year 2006.



- 11 -



---

##### Table of Contents

We continue to pursue opportunities that will add to our current product and service offerings in an effort to fulfill
the current demands in place, as well as, drive the continuous improvement of the billing and inventory processes that support the clinics.

8.
Subsequent Events

On July 31, 2006, we changed our name to Medical Solutions Management Inc. from China Media Networks
International, Inc. for the primary reason to better clarify the identity of the Company and to reflect the Companys evolution to a provider of medical devices. In connection with our name change, we filed a Schedule 14C Information
Statement with the Securities and Exchange Commission and delivered such statement to our stockholders.



- 12 -



---

##### Table of Contents

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

The following discussion and
analysis of our financial condition and plan of operations should be read in conjunction with the financial statements and the related notes. This discussion contains forward-looking statements based upon current expectations that involve risks and
uncertainties, such as our plans, objectives, expectations and intentions. Our actual results and the timing of certain events could differ materially from those anticipated in these forward-looking statements as a result of certain factors,
including those set forth in Annual Report on Form 10-KSB for the fiscal year ended December 31, 2005 under Risk Factors, Managements Discussion and Analysis or Plan of Operations and
Business.

Background

On July 31, 2006, we changed our name to Medical Solutions Management Inc. (referred to herein as MSMI) from China Media Networks International, Inc. On December 30, 2005, MSMI consummated a
merger transaction with our then wholly-owned subsidiary, CMNW Acquisition Corporation, OrthoSupply, Thunderbird Global Corporation and Mark L. Baum. Pursuant to the merger, CMNW Acquisition Corporation merged with and into OrthoSupply, CMNW
Acquisition Corporation ceased to exist, and OrthoSupply continued as the surviving corporation and wholly-owned subsidiary of MSMI. OrthoSupply acts as our operating company and MSMI is the parent holding company, and sole stockholder, of
OrthoSupply.

Prior to consummation of the merger, MSMI ceased all existing operations effective as of January 14, 2003. OrthoSupply
has generated revenue from its operation since February 2005. The discussion below focuses upon OrthoSupplys financial condition, results of operations and liquidity and capital resources.

Our Business

We are a provider of orthopedic
and podiatric durable medical equipment, specializing in the provision of services using our turnkey program. Through our turnkey program, we enable orthopedic and podiatric practices to dispense an array of durable medical equipment directly to
their patients during office visits. The system, which is transportable to other types of medical practices, also provides billing services, inventory management and insurance verifications.

Results of Operations

We operate our business
on a calendar year basis, with our fiscal year always ending on the Saturday closest to December 31 and each quarter ending on the 13thcalendar week.

Three Months Ended July 1, 2006 Compared to Three Months Ended July 2, 2005

Net Revenue.Set forth below are the net revenues.



|      |  |                    |         |              |   |            |  |   |         |  |     
|----- |  | ------------------ | ------- | ------------ | - | ---------- |  | - | ------- |  | ----
|      |  | Three Months Ended |         | Increase     |   | % Increase
|      |  | July 1, 2006       |         | July 2, 2005 |   |           
|Sales |  | $                  | 253,502 |              | $ | 127,045    |  | $ | 126,457 |  | 99.5

Net revenues increased primarily due to the number of clinics operating increasing from 5 in 2005
to 18 in 2006. Expansion into new regions throughout the United States has been driving the factor for the increase in clinics as we continue to ramp up our operations. A total of 4 clinics were added during the period ended July 1, 2006.



- 13 -



---

##### Table of Contents

Cost of Sales.Set forth below are the cost of sales.



|                            |  |                    |         |              |      |              |   |              |  |      |  |   |         |  |      
|--------------------------- |  | ------------------ | ------- | ------------ | ---- | ------------ | - | ------------ |  | ---- |  | - | ------- |  | -----
|                            |  | Three Months Ended |         | Increase     |      | %Increase   
|                            |  | July 1, 2006       |         | % of Revenue |      | July 2, 2005 |   | % of Revenue |  |     
|Costs of Goods and Services |  | $                  | 229,262 |              | 90.4 |              | $ | 69,867       |  | 54.9 |  | $ | 159,395 |  | 228.1

Cost of sales increased primarily due to the increased sales from the additional operating
clinics compared to 2005. Cost of sales as a percentage of revenue increased due to the addition of field operations staff and the recognition of a reserve for obsolete inventories, both of which were not present in 2005.

Operating Expenses.Set forth below are the operating expenses.



|                             |  |                    |         |              |       |              |   |              |  |       |  |   |         |  |        
|---------------------------- |  | ------------------ | ------- | ------------ | ----- | ------------ | - | ------------ |  | ----- |  | - | ------- |  | -------
|                             |  | Three Months Ended |         | Increase     |       | %Increase   
|                             |  | July 1, 2006       |         | % of Revenue |       | July 2, 2005 |   | % of Revenue |  |      
|Salaries & benefits          |  |                    | 233,016 |              | 91.9  |              |   | 104,971      |  | 82.6  |  |   | 128,045 |  | 121.9  
|Legal, consulting, insurance |  |                    | 356,419 |              | 140.6 |              |   | 16,240       |  | 12.8  |  |   | 340,179 |  | 2,094.7
|All Other                    |  |                    | 223,637 |              | 88.2  |              |   | 41,220       |  | 32.4  |  |   | 182,417 |  | 442.5  
|                             |  |                    |         |              |       |              |   |              |  |       |  |   |         |  |        
|Operating Expenses           |  | $                  | 813,072 |              | 320.7 |              | $ | 162,431      |  | 127.8 |  | $ | 650,641 |  | 400.5  

Salaries & Benefits Expense.

Salaries & benefits expense increased due to an increase in sales, administrative and service staff as we continue to ramp up our operation.
Total employees for the comparable period in 2005 were 5, compared to 15 in 2006. We expect to continue to add additional sales and service support staff as we expand our operation.

Legal, Consulting & Insurance Expenses.

Legal expense has increased dramatically to $186,612 for the period ended July 1, 2006 compared to $0 for the comparable period in 2005. These expenses are primarily related to services rendered surrounding the
various capital raises, securities exchange agreements and general counsel for operations. Consulting expense has also increased due to various independent contractor agreements, such as the $87,581 recognized for the valuation of warrants issued to
FP Associates, for services rendered for financing arrangements to potential acquisitions. Insurance expenses have also increased to support the various requirements set forth by industry standards and investment agreements.



- 14 -



---

##### Table of Contents

All Other Expenses

Recruitment fees of $23,480, rent of $38,792 and $60,000 of expenses related to the convertible debenture financing as well as general expenses to support a growing operation are the driving factors for the increase
in expenses from 2005 to 2006.

Net Loss.Set forth below is the net loss.



|         |  |                    |            |   |              |        |   |              |   |          |              |  |       |                     |  |   |                       |   |  |          |  
|-------- |  | ------------------ | ---------- | - | ------------ | ------ | - | ------------ | - | -------- | ------------ |  | ----- | ------------------- |  | - | --------------------- | - |  | -------- | -
|         |  | Three Months Ended |            |   |              |        |   |              |  
|         |  | July 1, 2006       |            |   | % of Revenue |        |   | July 2, 2005 |   |          | % of Revenue |  |       | Increase (Decrease) |  |   | % Increase (Decrease) |  
|Net Loss |  | $                  | (1,625,378 | ) |              | (641.1 | ) |              | $ | (105,253 | )            |  | (82.8 | )                   |  | $ | (1,520,125            | ) |  | (1,444.2 | )

This loss was attributable to selling and administrative costs as MSMI continues to ramp up its
operations, introducing new clinics, building a national sales force and hiring organized support for future clinics. A one time lump sum of $820,144 for interest expense was realized in June due to the discount arising from the computed beneficial
conversion feature associated with the senior secured convertible debenture sold to Vicis on June 28, 2006. We are required to expense the entire amount due to the conversion feature of the debenture being convertible immediately at the
discretion of the note holder. We also recognized $820,144 of a discount to the debenture which will be amortized using the effective interest method over the two year period of the note.

Our reserve for doubtful accounts. Our reserve amount is based upon estimated losses for customers who were billed directly for
products and services. For the three months ended July 1, 2006, we reserved 8.5% of revenues, or $21,616. The reserve amount is based on the sum of accounts receivable greater than 120 days. No reserve was recorded for the comparable period in
2005. We have not written off any accounts receivable to date.

Our reserve for excess or obsolete inventories.We provide
reserves for estimated excess, obsolete and shrink during the start-up phase of a clinic. For the three months ended July 1, 2006, we have provided $33,720 for a reserve, as a result of the following method. Our reserve formula, modified during
the second quarter of 2006 based on recent experience, is calculated by 25% of the inventory value for operating clinics in the period ended July 1, 2006. No reserve was recorded fro the comparable period in 2005.

Six Months Ended July 1, 2006 Compared to Six Months Ended July 2, 2005

Net Revenue. Set forth below are the net revenues.



|      |  |                  |         |              |   |            |  |   |         |  |      
|----- |  | ---------------- | ------- | ------------ | - | ---------- |  | - | ------- |  | -----
|      |  | Six Months Ended |         | Increase     |   | % Increase
|      |  | July 1, 2006     |         | July 2, 2005 |   |           
|Sales |  | $                | 407,165 |              | $ | 147,899    |  | $ | 259,266 |  | 175.3

Expansion into new regions of the United States and an overall increase in operating clinics of 14
from 2005 is the driving factor in the increase in net revenue. A total of 7 clinics have been added during the six months ended July 1, 2006.



- 15 -



---

##### Table of Contents

Cost of Sales.Set forth below are the cost of sales.



|                            |  |                  |         |              |      |              |   |              |  |      |  |   |         |  |      
|--------------------------- |  | ---------------- | ------- | ------------ | ---- | ------------ | - | ------------ |  | ---- |  | - | ------- |  | -----
|                            |  | Six Months Ended |         | Increase     |      | % Increase  
|                            |  | July 1, 2006     |         | % of Revenue |      | July 2, 2005 |   | % of Revenue |  |     
|Costs of Goods and Services |  | $                | 339,185 |              | 83.3 |              | $ | 102,287      |  | 69.1 |  | $ | 236,898 |  | 231.6

Cost of sales increased primarily due to the increased sales from an increase in operating
clinics from 2005. Cost of sales as a percentage of revenue increased due to the addition of field operations staff and the recognition of a reserve for obsolete inventories, both of which were not present in 2005. These expenses result in $50,544
and $34,520 of additional expense from 2005, respectively.

Operating Expenses. Set forth below are the operating
expenses.



|                             |  |                  |           |              |       |              |   |              |  |       |  |   |           |  |        
|---------------------------- |  | ---------------- | --------- | ------------ | ----- | ------------ | - | ------------ |  | ----- |  | - | --------- |  | -------
|                             |  | Six Months Ended |           | Increase     |       | % Increase  
|                             |  | July 1, 2006     |           | % of Revenue |       | July 2, 2005 |   | % of Revenue |  |      
|Salaries & benefits          |  |                  | 469,556   |              | 115.3 |              |   | 108,045      |  | 73.0  |  |   | 361,511   |  | 334.6  
|Legal, consulting, insurance |  |                  | 544,561   |              | 133.7 |              |   | 16,240       |  | 10.9  |  |   | 528,321   |  | 3,253.2
|All Other                    |  |                  | 310,837   |              | 76.3  |              |   | 79,577       |  | 53.8  |  |   | 231,260   |  | 290.6  
|                             |  |                  |           |              |       |              |   |              |  |       |  |   |           |  |        
|Operating Expenses           |  | $                | 1,324,954 |              | 325.4 |              | $ | 203,862      |  | 137.8 |  | $ | 1,121,092 |  | 549.9  

Salaries & Benefits Expense.

Salaries & benefits expense increased due to an increase in sales, administrative and service staff as we continue to ramp up our operation.
Total employees for the comparable period in 2005 were 5, compared to 15 in 2006. We expect to continue to add additional sales and service support staff as we expand our operation.

Legal, Consulting & Insurance Expenses.

Legal expense has increased dramatically to $344,781 for the period ended July 1, 2006 compared to $0 for the comparable period in 2005. These expenses are primarily related to services rendered surrounding the
various capital raises, securities exchange agreements and general counsel for operations. Consulting expense has also increased due to various independent contractor agreements, such as the $87,581 recognized for the valuation of warrants issued to
FP Associates, for services rendered for financing arrangements to potential acquisitions. Insurance expenses have also increased to $34,639 in 2006 compared to $5,741 in 2005, to support the various requirements set forth by industry standards and
investment agreements.



- 16 -



---

##### Table of Contents

All Other Expenses

Recruitment fees of $23,480, rent of $38,792 and $60,000 of expenses related to the convertible debenture financing as well as general expenses to support a growing operation are the driving factors for the increase
in other expenses from 2005 to 2006. Billing service fees have also increased from $11,724 in 2005 to $30,777 in 2006, again resulting from the increase in operating clinics for the comparable periods.

Net Loss.Set forth below is the net loss.



|         |  |                  |            |   |                    |        |   |                     |   |          |             |  |        |   |  |   |            |   |  |          |  
|-------- |  | ---------------- | ---------- | - | ------------------ | ------ | - | ------------------- | - | -------- | ----------- |  | ------ | - |  | - | ---------- | - |  | -------- | -
|         |  | Six Months Ended |            |   | Increase(Decrease) |        |   | %Increase(Decrease) |  
|         |  | July 1, 2006     |            |   | % of Revenue       |        |   | July 2, 2005        |   |          | % ofRevenue |  |        |  
|Net Loss |  | $                | (2,074,273 | ) |                    | (509.4 | ) |                     | $ | (158,250 | )           |  | (106.9 | ) |  | $ | (1,916,023 | ) |  | (1,210.7 | )

This loss was attributable to selling and administrative costs as MSMI continues to ramp up its
operations, introducing new clinics, building a national sales force and hiring organized support for future clinics. A one time lump sum of $820,144 for interest expense was realized in June due to the discount arising from the computed beneficial
conversion feature associated with the senior secured convertible debenture sold to Vicis on June 28, 2006. We are required to expense the entire amount due to the conversion feature of the debenture being convertible immediately at the
discretion of the note holder. We also recognized $820,144 of a discount to the debenture which will be amortized using the effective interest method over the two year period of the note.

Liquidity and Capital Resources

Cash used in
operations during the first six months ended July 1, 2006 was $1,267,107, compared to $197,559 in 2005; however, financing activities from the $2,000,000 senior convertible debenture consummated on June 28, 2006, resulted in an overall net
change in cash of $726,481. Comparatively, borrowings from related parties in the amount of $215,924 in 2005, resulted in a net change in cash of $3,275 for the comparable period in 2005. As of July 1, 2006 we had $1,849,826 in total assets,
compared to $176,211 in 2005, of which $1,426,221, $3,275 in 2005, was in cash and cash equivalents, and our total liabilities were $1,491,512, compared to $96,147 in 2005. We expect that our current cash availability will support current operations
through the end of 2006. We anticipate that we will need to complete additional financing to support current working capital needs and potential acquisitions. Through these financings, we hope to expand the business organically and acquisitively.

Our reserve for doubtful accounts. Our reserve amount is based upon estimated losses for customers who were billed
directly for products and services. For the first six months ended July 1, 2006, we reserved 8% of revenues, or $33,644. The reserve amount is based on the sum of accounts receivable greater than 120 days. No reserve was recorded for the
comparable period in 2005. We have not written off any accounts receivable to date.

Our reserve for excess or obsolete inventories.We provide reserves for estimated excess, obsolete and shrink during the start-up phase of a clinic. For the first six months ended July 1, 2006, we have provided $34,668 for a reserve, as a result of the following method. Our reserve
formula, modified during the second quarter of 2006 based on recent experience, is calculated by 25% of the inventory value for operating clinics in the period ended July 1, 2006. No reserve was recorded fro the comparable period in 2005.



- 17 -



---

##### Table of Contents

Plan of Operations

Our main objectives for the next 12 months are to continuing our ability to finance the Company and focusing on expanding revenue in key locations across the country. We are currently pursuing additional follow-on
financing to support current working capital needs and potential acquisitions. We expect that our current cash availability will support current operations through the end of 2006. Through these financings, we hope to expand the business organically
and acquisitively.

Our plan for organic growth includes increasing our sales force in key locations across the country. In fiscal year
2006, we plan to build our sales force from our current level of 4 sales people to 10 regional sales people. The plan includes support programs for the sales efforts including marketing, communications and program literature.

We also plan to increase our resources in administration, and to add one to three additional employees to assist with our service administration. During
the first six months of 2006, we hired two additional customer support specialists and two field representative in order to carry out our current service model. We expect to hire additional field support resources to support the growth in new
clinics during 2006.

We do not anticipate devoting our resources to research and development in fiscal year 2006.

We continue to pursue opportunities that will add to our current product and service offerings in an effort to fulfill the current demands in place, as
well as, drive the continuous improvement of the billing and inventory processes that support the clinics.

Critical Accounting Policies and
Estimates

Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial
statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to contractual allowances, doubtful accounts, inventories,
rebates, product returns, warranty obligations, income taxes, intangibles and investments. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of
which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our
consolidated financial statements, and this discussion and analysis of our financial condition and results of operations.

Recent Accounting
Pronouncements

On December 16, 2004, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 123
(revised 2004), Share-Based Payment, which is a revision of FASB Statement No. 123, Accounting for Stock-Based Compensation. Statement 123(R) supersedes APB Opinion No. 25, Accounting for Stock Issued to employees, and amends FASB
Statement No. 95, Statement of Cash Flows. The approach to accounting for share-based payments in Statement 123(R) is similar to the approach described in Statement 123. However, Statement 123(R) requires all share-based payments to employees,
including grants of employee stock options, to be recognized in the financial statements based on their fair values and no longer allows pro forma disclosure as an alternative to financial statement recognition. We were required to adopt Statement
123(R) at the beginning of our quarter January 1, 2006.



- 18 -



---

##### Table of Contents

EITF Issue 04-8, The Effect of Contingently Convertible Instruments on Diluted Earnings per
Share. The EITF reached a consensus that contingently convertible instruments, such as contingently convertible debt, contingently convertible preferred stock, and other such securities should be included in diluted earnings per share (if
dilutive) regardless of whether the market price trigger has been met. The consensus became effective for reporting periods ending after December 15, 2004. The adoption of this pronouncement does not currently have an effect on the
Companys financial statements because the inclusion of common stock equivalents in earnings per share is anti-dilutive.

In
September 2005, the FASB ratified the Emerging Issues Task Forces (EITF) Issue No. 05-7, Accounting for Modifications to Conversion Options Embedded in Debt Instruments and Related Issues, which addresses
whether a modification to a conversion option that changes its fair value affects the recognition of interest expense for the associated debt instrument after the modification and whether a borrower should recognize a beneficial conversion feature
not a debt extinguishment if a debt modification increases the intrinsic value of the debt (for example, the modification reduces the conversion price of the debt). In September 2005, the FASB also ratified the EITFs Issue No. 05-8,
Income Tax Consequences of Issuing Convertible Debt with a Beneficial Conversion Feature, which discusses whether the issuance of convertible debt with a beneficial conversion feature results in a basis difference arising from the
intrinsic value of the beneficial conversion feature on the commitment date (which is treated recorded in the shareholders equity for book purposes, but as a liability for income tax purposes), and, if so, whether that basis difference is a
temporary difference under FASB Statement No. 109, Accounting for Income Taxes. The Company is currently in the process of evaluating the effect that the adoption of this pronouncement may have on its financial statements.

In September 2005, the FASB also ratified the EITFs Issue No. 05-8, Income Tax Consequences of Issuing Convertible
Debt with a Beneficial Conversion Feature, which discusses whether the issuance of convertible debt with a beneficial conversion feature results in a basis difference arising from the intrinsic value of the beneficial conversion feature on the
commitment date (which is treated recorded in the shareholders equity for book purposes, but as a liability for income tax purposes), and, if so, whether that basis difference is a temporary difference under FASB Statement No. 109,
Accounting for Income Taxes. We currently carry an allowance for all deferred taxes and, therefore we do not believe the adoption of this pronouncement will have any impact on our financial statements.

Off Balance Sheet Arrangements

We do not have
any off balance sheet arrangements.

ITEM 3. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures.As required by
Rule 13a-15 under the Exchange Act, as of the end of the period covered by this report, we carried out an evaluation under the supervision and with the participation of our management, including our President and Treasurer (our acting principal
executive officer and principal accounting and finance officer), of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating our disclosure controls and procedures, we and our management
recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating
and implementing possible controls and procedures. The effectiveness of our disclosure controls and procedures and our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used
in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the
risk



- 19 -



---

##### Table of Contents

that controls may become inadequate because of changes in conditions and the risk that the degree of compliance with
policies or procedures may deteriorate over time. Because of these limitations, there can be no assurance that any system of disclosure controls and procedures or internal control over financial reporting will be successful in preventing all errors
or fraud or in making all material information known in a timely manner to the appropriate levels of management.

A control deficiency
exists when the design or operation of a control does not allow management or employees, in the ordinary course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control
deficiency, or combination of control deficiencies, that adversely affects the Companys ability to initiate, authorize, record, process, or report external financial data reliably in accordance with GAAP, such that there is a more than remote
likelihood that a misstatement of the Companys annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a control deficiency, or combination of control deficiencies,
that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

Based upon an evaluation conducted for the period ended July 1, 2006, our President and Treasurer (our acting principal executive officer and principal accounting and finance officer) has concluded that as of the
end of the period covered by this report, we have identified the following material weaknesses:



| |  |  | Reliance upon independent financial reporting consultants for review of critical accounting areas and disclosures and material non-standard transactions.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | A limited number of on-site accounting personnel which results in a lack of segregation of duties necessary for a good system of internal control.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------

Managements review of our internal controls is on-going and will take whatever measures necessary to reduce the material deficiencies noted.
Implementation of our remediation plan may include hiring additional permanent employees, establishing additional training programs and/or engaging outside expert consultants. The effectiveness of the steps we have taken to date and the steps we are
still in the process of completing is subject to continued management review, and we may make additional changes to our internal controls and procedures. Although we have undertaken the foregoing initiatives, we cannot assure you that we will not in
the future identify further material weaknesses in our internal control over financial reporting that we have not discovered to date. We will continue to review and document our disclosure controls and procedures, including our internal controls and
procedures for financial reporting, on an ongoing basis, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

Changes in internal control over financial reporting.There was no change in our internal control over financial reporting that occurred during
the period covered by this report on Form 10-QSB that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.



- 20 -



---

##### Table of Contents

PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not involved in nor a party to any material legal
proceedings.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Pursuant to the Exchange
Agreement among the Registrant, Vicis, Midtown Partners & Co., LLC and Nite Capital L.P., dated as of April 13, 2006, such shareholders assigned, exchanged and converted their right, title and interest to shares of the
Registrants then outstanding Series A Preferred Stock and, in exchange thereof and upon such conversion, the Registrant issued such shareholders shares of the Registrants common stock, as set forth below, and, as a result, there are no
shares of Series A Preferred Stock presently outstanding.



|                            |  |                                                                                |  |                                        
|--------------------------- |  | ------------------------------------------------------------------------------ |  | ---------------------------------------
|Shareholder                 |  | Number of Shares of Series A Preferred Stock Assigned, Exchanged
and Converted |  | Number of Shares of Common Stock Issued
|Vicis Capital Master Fund   |  | 1,500,000                                                                      |  | 2,000,000                              
|Midtown Partners & Co., LLC |  | 90,000                                                                         |  | 120,000                                
|Nite Capital L.P.           |  | 110,000                                                                        |  | 220,000                                

On May 3, 2006, the Registrant entered into a Securities Purchase Agreement with Vicis,
pursuant to which the Registrant sold a convertible note in the original principal amount of $300,000 and 300,000 shares of the Registrants common stock, in exchange for $300,000. Vicis surrendered the note as partial consideration for the 6%
senior secured convertible debenture described above

On June 28, 2006, the Registrant consummated a Securities Purchase and Exchange
Agreement with Vicis Capital Master Fund, or Vicis. Pursuant to this agreement, the Registrant sold to Vicis a 6% senior secured convertible debenture in the original principal amount of $2,000,000, a warrant to purchase 8,000,000 shares of the
Registrants common stock, exercisable for five years at a price of $0.345 per share, and a warrant to purchase 8,000,000 shares of the Registrants common stock, exercisable for five years at price of $0.375 per share. As consideration
there of, Vicis paid the Registrant $1,700,000 cash less $60,000 for incurred expenses and surrendered a convertible note in the principal amount of $300,000 previously sold to Vicis on May 3, 2006 and 1,994,419 shares of the Registrants
common stock.

On June 28, 2006, the Registrant issued to FP Associates a warrant to purchase 300,000 shares of the Registrants
common stock, exercisable for five years at a price of $0.01 per share, in consideration for services rendered to the Registrant. The Registrant relied upon Rule 506 of Regulation D of the Securities Act of 1933, as amended, for the issuance of the
debenture and warrants to Vicis and the warrant to FP Associates.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On June 28, 2006, holders of approximately
98.8% of MSMIs issued and outstanding common stock consented in writing to the adoption of resolutions approving MSMIs amended and restated articles of incorporation which, among other things, changed MSMIs name to Medical
Solutions Management Inc. and its authorized capital stock to 100,000,000 shares of common stock and 5,000,000 shares of undesignated preferred stock. These stockholders also consented in writing to the adoption of resolutions approving
MSMIs 2006 Equity Incentive Plan pursuant to which 3,000,000 shares of common stock are reserved for issuance thereunder.



- 21 -



---

##### Table of Contents

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS



|            |  |                                                                                                                                                                                                                                                                                                                                 
|----------- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                                                                                                                                                                                                                     
|3.1         |  | Amended and Restated Articles of Incorporation of the Registrant (incorporated by reference to Appendix A to the Registrants Definitive Information Statement on Schedule 14C filed on July
11, 2006)                                                                                                                          
|            | 
|3.2         |  | Amended and Restated Bylaws of the Registrant (incorporated by reference to Appendix C from the Registrants Definitive Information Statement on Schedule 14C filed on July 11,
2006)                                                                                                                                           
|            | 
|3.3         |  | Employment Agreement dated as of May 1, 2006, by and between the Registrant and Robert G. Coffill, Jr. (incorporated by reference to Exhibit 10.2 to the Registrants Registration Statement
on Form SB-2 filed on August 8, 2006)                                                                                              
|            | 
|3.4         |  | Employment Agreement dated as of June 12, 2006, by and between the Registrant and Ross Fine (incorporated by reference to Exhibit 10.4 to the Registrants Registration Statement on Form
SB-2 filed on August 8, 2006)                                                                                                         
|            | 
|3.5         |  | Medical Solutions Management Inc. 2006 Equity Incentive Plan (incorporated by reference to Appendix C to the Registrants Definitive Information Statement on Schedule 14C filed on July 11,
2006)                                                                                                                              
|            | 
|3.6         |  | Independent Contractor Agreement, effective as of April 1, 2006, by and between the Registrant and FP Associates (incorporated by reference to Exhibit 10.9 to the Registrants Registration
Statement on Form SB-2 filed on August 8, 2006)                                                                                    
|            | 
|3.7         |  | Exchange Agreement dated as of April 13, 2006, by and among the Registrant, Vicis Capital Master Fund, Midtown Partners & Co., LLC and Nite Capital L.P. (incorporated by reference to
Exhibit 10.8 to the Registration Statement filed on April 14, 2006)                                                                      
|            | 
|3.8         |  | Securities Purchase Agreement dated as of May 3, 2006, by and between the Registrant and Vice Capital Master Fund (incorporated by reference to Exhibit 10.11 to the Registrants
Registration Statement on Form SB-2 filed on August 8, 2006)                                                                                  
|            | 
|3.9         |  | Securities Purchase and Exchange Agreement dated as of June 28, 2006 by and between the Registrant and Vicis Capital Master Fund (incorporated by reference to Exhibit 10.12 to the
Registrants Registration Statement on Form SB-2 filed on August 8, 2006)                                                                   
|            | 
|3.10        |  | Amended and Restated Investor Rights Agreement dated as of June 28, 2006 by and among the Registrant, John Hallal, Patricia Jenkins, FP Associates, Vicis Capital Master Fund and Nite Capital
L.P. (incorporated by reference to Exhibit 10.13 to the Registrants Registration Statement on Form SB-2 filed on August 8, 2006)



- 22 -



---

##### Table of Contents

|     |  |                                                                                                                                                                     
|---- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------
|31.1 |  | Certification of principal executive officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                             
|     | 
|31.2 |  | Certification of principal accounting and finance officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                
|     | 
|32.1 |  | Certification of principal executive officer and principal accounting and finance officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (filed herewith)



- 23 -



---

##### Table of Contents

MEDICAL SOLUTIONS MANAGEMENT INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.



|                      |  |                                   |  |                                                                           
|--------------------- |  | --------------------------------- |  | --------------------------------------------------------------------------
|                      |  | MEDICAL SOLUTIONS MANAGEMENT INC.
|                      |  |                                  
|Date: August 15, 2006 |  | By:                               |  | /s/ Brian Lesperance                                                      
|                      |  |                                   |  | Brian Lesperance                                                          
|                      |  |                                   |  | President and Treasurer                                                   
|                      |  |                                   |  | (principal executive officer and principal accounting and finance officer)



- 24 -